Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board
MINNEAPOLIS, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying ...
Tag: STREAMWAY
Precision Therapeutics Reports Second Quarter 2018 Financial Results
Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end of 2018 MINNEAPOLIS, Aug. 14, 2018 ...
Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform
MINNEAPOLIS, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial ...
Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange
MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial ...
Precision Therapeutics Launches New Website
MINNEAPOLIS, May 31, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence ...
Video News on Precision Therapeutics Inc (Nasdaq: AIPT) – Company Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
Video News On PRECISION THERAPEUTICS, INC. - NASDAQ: AIPT https://youtu.be/G7Vc44qfBMQ About the STREAMWAY System Skyline's revolutionary, FDA-cleared STREAMWAY ...
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
MINNEAPOLIS, May 10, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence ...
Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares
MINNEAPOLIS, (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine ...
Precision Therapeutics Reports Fiscal Year 2017 Financial Results
Company reports strengthening STREAMWAY® System sales and new strategic focus on the emerging precision medicine market MINNEAPOLIS, April 02, 2018 ...
Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018
Sixteen STREAMWAY Systems sold in Q1 2018, compared with five units sold in Q4 2017 and three sold in Q1 ...
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
MINNEAPOLIS, March 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its ...
© Copyright 2022 publicwire.com